- Home
- CNTX vs HYPR Comparison
CNTX vs HYPR Comparison
Compare CNTX & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- HYPR
- Stock Information
- Founded
- CNTX 2015
- HYPR 2014
- Country
- CNTX United States
- HYPR United States
- Employees
- CNTX N/A
- HYPR N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- CNTX Health Care
- HYPR Health Care
- Exchange
- CNTX Nasdaq
- HYPR Nasdaq
- Market Cap
- CNTX 77.2M
- HYPR 66.4M
- IPO Year
- CNTX 2021
- HYPR N/A
- Fundamental
- Price
- CNTX $0.96
- HYPR $0.97
- Analyst Decision
- CNTX Strong Buy
- HYPR Hold
- Analyst Count
- CNTX 5
- HYPR 1
- Target Price
- CNTX $6.70
- HYPR $1.60
- AVG Volume (30 Days)
- CNTX 1.1M
- HYPR 141.1K
- Earning Date
- CNTX 11-06-2024
- HYPR 11-12-2024
- Dividend Yield
- CNTX N/A
- HYPR N/A
- EPS Growth
- CNTX N/A
- HYPR N/A
- EPS
- CNTX N/A
- HYPR N/A
- Revenue
- CNTX N/A
- HYPR $13,255,000.00
- Revenue This Year
- CNTX N/A
- HYPR $31.75
- Revenue Next Year
- CNTX N/A
- HYPR $29.82
- P/E Ratio
- CNTX N/A
- HYPR N/A
- Revenue Growth
- CNTX N/A
- HYPR 35.67
- 52 Week Low
- CNTX $0.89
- HYPR $0.76
- 52 Week High
- CNTX $2.75
- HYPR $1.39
- Technical
- Relative Strength Index (RSI)
- CNTX 38.22
- HYPR 51.61
- Support Level
- CNTX $0.92
- HYPR $0.92
- Resistance Level
- CNTX $1.05
- HYPR $0.99
- Average True Range (ATR)
- CNTX 0.13
- HYPR 0.07
- MACD
- CNTX 0.01
- HYPR 0.00
- Stochastic Oscillator
- CNTX 17.78
- HYPR 47.81
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.